Monitoring and Evaluation Study of Project ECHO for ILD

NCT05455437 | Unknown

• 1 other identifier: ILDC-002
• Study Type: observational
• Target: 200
• Locations: 1 country
• Sites: 1

Brief Summary

The study will utilize pre-post survey measures to evaluate Project ECHO for ILD with respect to an initial set of practice and clinical outcomes and relies on questionnaire data obtained from providers participating in Project ECHO for ILD at baseline, at 6 months, and at study end.

Conditions

Interstitial Lung Diseases

Keywords

Progressive Fibrosing Interstitial Lung Disease; Idiopathic Pulmonary Fibrosis; Interstitial Lung Disease Associated With Systemic Sclerosis; Myositis-Associated Interstitial Lung Disease; Sarcoidosis; Hypersensitivity Pneumonitis; Pulmonary Fibrosis

Outcome Measures

Primary Outcomes (2)

• Impact on procedural knowledge

  Change in participants' skills or competence in knowing ILD testing and treatment procedures based on a Likert scale rating (1=no skill and 7=expert, teach other) included in the structured participant surveys administered at baseline, 6 months, and at study end.

  Up to 18 months

• Impact on local care utilization

  Change of proportion of patients utilizing local ILD care services, including the frequency of local follow-up visits and testing. Change in scores will be calculated between structured participant surveys responses at baseline, 6 months, and at study end.

  Up to 18 months

Secondary Outcomes (2)

• Time to ILD diagnosis

  Up to 18 months

• Content expert facilitation

  Up to 18 months

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Pulmonologists and primary care physicians who participate in Project ECHO for ILD.

You may qualify if:

• Pulmonologists and primary care physicians who participate in Project ECHO for ILD.

Sponsors & Collaborators

• Pulmonary Care and Research Collaborative Limited: lead
• Genentech, Inc.: collaborator

Study Sites (1)

Pulmonary Care and Research Collaborative, Ltd.

Boston, Massachusetts, 02130, United States

Location

MeSH Terms

Conditions

Lung Diseases, Interstitial; Idiopathic Pulmonary Fibrosis; Sarcoidosis; Alveolitis, Extrinsic Allergic; Pulmonary Fibrosis

Condition Hierarchy (Ancestors)

Lung Diseases; Respiratory Tract Diseases; Lymphoproliferative Disorders; Lymphatic Diseases; Hemic and Lymphatic Diseases; Hypersensitivity, Delayed; Hypersensitivity; Immune System Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Fibrosis; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Aliaa Barakat, PhD

  Pulmonary Care and Research Collaborative, Ltd.

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 30, 2022
• First Posted: July 13, 2022
• Study Start: July 1, 2022
• Primary Completion: December 1, 2023
• Study Completion: March 1, 2024
• Last Updated: July 13, 2022

Record last verified: 2022-07

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)